SB 2149
AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials.
Jurisdiction
Tennessee
Session
114th General Assembly
Last updated at
Jun 13, 2026, 8:49 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Bill overview
This bill, the HOPE Treatment Act, allows Tennessee research institutions to participate in clinical trials involving ibogaine, a substance sometimes used in treatment programs. It outlines specific conditions for these trials, including compliance with state and federal laws, and the requirement that ibogaine be administered only within hospitals or qualified research facilities under a Tennessee-licensed physician’s supervision. The bill also permits these institutions to receive and manage funding from various sources for these research activities. The legislation aims to facilitate research into ibogaine’s potential therapeutic uses while ensuring patient safety and legal compliance.
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.